ClinicalTrials.govpublic full text
Burosumab for Fibroblast Growth Factor-23 Mediated Hypophosphatemia in Fibrous Dysplasia
fibrous dysplasia of bone, mccune-albright syndrome, rickets, osteomalacia, metabolic bone disorders, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 801389
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.